In light of widespread interest in the prognostic value of biomarkers, we apply three discrimination measures to evaluate the incremental value of biomarkers—beyond self-reported measures—for predicting all-cause mortality. We assess whether all three measures—area under the receiver-operating characteristic curve, continuous net reclassification improvement, and integrated discrimination improvement—lead to the same conclusions.